Our Therapies

The first and only FDA-approved
treatment for Demodex blepharitis

SEC Filing Details

Document Details

Form
Filing Date
March 16, 2023
Document Date
March 16, 2023
Form Description
Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
Filing Group
Other
Company
Tarsus Pharmaceuticals
Issuer
TARSUS PHARMACEUTICALS, INC.